🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Waldenström's Macroglobulinemia (lymphoplasmacytic lymphoma, WM) remains in...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2006-09
Trial ID
NCT00422656
Treatments Being Tested
Up to 90% of patients with Parkinson's disease (PD) have hypokinetic dysart...
Status
Unknown
Location
Central European Institute of Technology
Start Date
2023-01-10
Trial ID
NCT06416553
This is a phase II open-label study evaluating the pharmacokinetics and pha...
Status
Withdrawn
Location
St. Boniface General Hospital Research Centre
Start Date
2020-01
Trial ID
NCT04025177
Treatments Being Tested
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Status
Terminated
Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
Start Date
2013-03-15
Trial ID
NCT01732211
Treatments Being Tested
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested
To learn if the drug combination of tiragolumab and ivonescimab can help to...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-07-28
Trial ID
NCT07038915
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
This study will examine the long-term safety of buntanetap in participants ...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2026-01-09
Trial ID
NCT07284784
Treatments Being Tested